Search for: "Astrazeneca" Results 601 - 620 of 1,246
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Mar 2012, 9:25 pm by Patent Docs
AstraZeneca AB et al v. [read post]
24 Mar 2012, 1:20 pm by Stewart Walsh
AstraZeneca Pharmaceuticals LP to surprise, and unpleasantly upend the patentee. [read post]
23 Mar 2012, 4:00 am by tracey
& Anor [2012] EWHC 716 (Ch) (22 March 2012) Rohl v Bickland Ltd [2012] EWHC 706 (Ch) (22 March 2012) High Court (Patents Court) Teva UK Ltd & Ors v Astrazeneca AB [2012] EWHC 655 (Pat) (22 March 2012) Regeneron Pharmacueticals Inc v Genentech Inc [2012] EWHC 657 (Pat) (22 March 2012) Source: www.bailii.org [read post]
20 Mar 2012, 2:29 pm by JA Hodnicki
ABSTRACT: In the landmark 2005 Article 102 TFEU case regarding Losec, AstraZeneca was fined EUR 60 million for conduct that would not... [read post]
20 Mar 2012, 2:29 pm by JA Hodnicki
ABSTRACT: In the landmark 2005 Article 102 TFEU case regarding Losec, AstraZeneca was fined EUR 60 million for conduct that would not... [read post]
11 Mar 2012, 3:32 pm by Mark Summerfield
Apotex Pty Ltd v AstraZeneca AB (No 2) [2012] FCA 142 (28 February 2012) Watson Pharma Pty Ltd v AstraZeneca AB [2012] FCA 200 (9 March 2012) Interlocutory injunctions – prima facie case – balance of convenience – whether additional evidence provides grounds to vary previous findings At least five Australian pharmaceutical manufacturers are now ready to launch generic versions of cholesterol-lowering drug CRESTOR, while being barred from doing so pending the… [read post]
8 Mar 2012, 3:34 am by Dan Hargrove
The federation, which goes by the acronym IFPMA, is led by David Brennan, an American who is also chief executive of AstraZeneca. [read post]
7 Mar 2012, 5:32 am by Mark Summerfield
Apotex Pty Ltd v AstraZeneca AB [2011] FCA 1520 (14 December 2011) Interlocutory injunctions – prima facie case – balance of convenience – relevance of delay by patentee, complexity of proceedings, and parties’ conduct and obligations In the first Federal Court decision to follow the ruling of the Full Court in Samsung v Apple (see Samsung v Apple – A Closer Look at the Appeal Decision) Justice Rares has granted a preliminary injunction to pharmaceutical… [read post]
2 Mar 2012, 6:52 am by Bexis
Astrazeneca (Crestor) Daubert Hearing2007-06-14 Fleet Phospho-Soda Litig. [read post]
28 Feb 2012, 6:06 pm by Mark Zamora
The Food and Drug Administration announced on Tuesday the changes to the safety information on the labels of statins such as Pfizer Inc's Lipitor, AstraZeneca's Crestor and Merck & Co's Zocor that are taken by tens of millions of people.Statins have been shown to significantly reduce the risk of heart attack and heart disease, and the FDA said the new information should not scare people into stopping taking the drugs. [read post]
27 Feb 2012, 3:30 am
AstraZeneca Pharmaceuticals, LP, No. 1:10CV104-SA-JAD, 2010 WL 3951906 (N.D. [read post]
13 Feb 2012, 12:54 pm by Pilar G. Kraman
On February 2, 2012, Judge Stark issued a Memorandum Opinion construing the following claim term of AstraZeneca's U.S. [read post]
11 Feb 2012, 7:33 pm by Dennis Crouch
By Dennis Crouch Astrazeneca v. [read post]
10 Feb 2012, 10:56 am by Courtney Minick
Court of Appeals for the Federal Circuit issued an opinion on a patent matter for AstraZeneca, the makers of Crestor. [read post]